Edition:
United Kingdom

ArQule Inc (ARQL.OQ)

ARQL.OQ on NASDAQ Stock Exchange Global Market

10.60USD
15 Jul 2019
Change (% chg)

-- (--)
Prev Close
$10.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
760,209
52-wk High
$12.21
52-wk Low
$2.23

About

ArQule, Inc. is a biopharmaceutical company that is engaged in the research and development of therapeutics to treat cancers and rare diseases. These drugs focus on the biological pathways implicated in a range of cancers and certain non-oncology indications. Its clinical-stage pipeline consists of approximately four drug... (more)

Overall

Beta: 2.18
Market Cap(Mil.): $1,269.17
Shares Outstanding(Mil.): 119.73
Dividend: --
Yield (%): --

Financials

  ARQL.OQ Industry Sector
P/E (TTM): -- 97.74 33.85
EPS (TTM): -0.17 -- --
ROI: -31.95 7.69 12.53
ROE: -47.58 8.13 17.18

BRIEF-Basilea Announces Collaboration To Study Derazantinib And Atezolizumab In Urothelial Cancer

* BASILEA ANNOUNCES COLLABORATION TO STUDY DERAZANTINIB AND ATEZOLIZUMAB (TECENTRIQ®) IN UROTHELIAL CANCER

24 Jan 2019

Earnings vs. Estimates